Literature DB >> 26007204

Para-aortic lymph node metastases in locally advanced cervical cancer: Comparison between surgical staging and imaging.

Armin Vandeperre1, Erik Van Limbergen2, Karin Leunen1, Philippe Moerman3, Frédéric Amant1, Ignace Vergote4.   

Abstract

OBJECTIVE: Compare surgical staging with imaging (PET-CT, PET or CT) of the para-aortic lymph nodes (PAOLN) in locally advanced cervical cancer (LACC).
METHODS: Monocentric retrospective study of 336 patients with cervical cancer FIGO stage IB2-IVA. All patients underwent staging of the PAOLN using imaging by PET-CT, PET or CT. Two hundred and four patients with normal or not overtly malignant PAOLN on imaging underwent surgical PAOLN staging up to the inferior mesenteric artery (189 endoscopy and 15 laparotomy).
RESULTS: The patients were divided into 4 groups: 16 with positive surgical staging and negative PAOLN imaging (sPAOLN+), 172 negative surgical staging (sPAOLN-), 20 positive imaging without surgical staging (iPAOLN+) and 128 negative imaging without surgical staging (iPAOLN-). Median operative time of staging was 70 (40-160) min and median number of removed PAOLN was 5 (0-24). Operative complications were 10 peroperative bleedings, 2 ureteral traumas, 1 carbon dioxide retention and 1 retroperitoneal abscess. The median follow-up was 31 (1-218) months. Overall survival at 2 years was for sPAOLN+, sPAOLN-, iPAOLN+, and iPAOLN- 40%, 83%, 58%, and 69%, respectively (p<0.001 for sPAOLN+ and iPAOLN+ versus sPAOLN- and iPAOLN-). The most frequent site of recurrence was distant LN metastases (outside the pelvic and PAO area) (36%) for sPAOLN+. For sPAOLN-, iPAOLN+, and iPAOLN- the most frequent site of recurrence was the cervix (27%, 66% and 26%, respectively).
CONCLUSION: Despite negative imaging, PAOLN metastases were present in 8% at surgical staging. Overall survival is significantly influenced by the presence of PAOLN metastases.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; PET/CT; Para-aortic lymphadenectomy; Staging

Mesh:

Year:  2015        PMID: 26007204     DOI: 10.1016/j.ygyno.2015.05.021

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  15 in total

Review 1.  [The 2019 FIGO classification for cervical carcinoma-what's new?]

Authors:  L-C Horn; C E Brambs; S Opitz; U A Ulrich; A K Höhn
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

Review 2.  The role of para-aortic nodal irradiation in cervical cancer.

Authors:  Adela Poitevin Chacón; Jessica Chavez-Nogueda; Rubí Ramos-Prudencio; Michelle Aline Villavicencio-Queijeiro; Francisco Lozano-Ruiz
Journal:  Rep Pract Oncol Radiother       Date:  2018-10-09

3.  Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?

Authors:  Fatih Gucer; Selim Misirlioglu; Nuri Ceydeli; Cagatay Taskiran
Journal:  J Robot Surg       Date:  2017-03-02

Review 4.  Multimodality imaging findings of infection-induced tumors.

Authors:  Moataz Soliman; Nicholas Guys; Peter Liu; Mariam Moshiri; Christine O Menias; Vincent M Mellnick; Hatice Savas; Mohamed Badawy; Khaled M Elsayes; Ayman H Gaballah
Journal:  Abdom Radiol (NY)       Date:  2022-09-07

Review 5.  Para-aortic lymph node involvement in cervical cancer: Implications for staging, outcome and treatment.

Authors:  T S Shylasree; Lavanya Gurram; Ushashree Das
Journal:  Indian J Med Res       Date:  2021-08       Impact factor: 5.274

Review 6.  Advances in diagnosis and treatment of metastatic cervical cancer.

Authors:  Haoran Li; Xiaohua Wu; Xi Cheng
Journal:  J Gynecol Oncol       Date:  2016-07       Impact factor: 4.401

7.  Para-aortic lymphadenectomy in advanced stage cervical cancer, a protocol for comparing safety, feasibility and diagnostic accuracy of surgical staging versus PET-CT; PALDISC trial.

Authors:  Casper Tax; Karin Abbink; Maroeska M Rovers; Ruud L M Bekkers; Petra L M Zusterzeel
Journal:  Pilot Feasibility Stud       Date:  2018-01-04

8.  Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience.

Authors:  Jie Lee; Jhen-Bin Lin; Fang-Ju Sun; Yu-Jen Chen; Chih-Long Chang; Ya-Ting Jan; Meng-Hao Wu
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

9.  Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer.

Authors:  Shin Nishio; Koji Matsuo; Koji Yonemoto; Mototsugu Shimokawa; Masayuki Hosaka; Michiko Kodama; Takahito M Miyake; Kimio Ushijima; Toshiharu Kamura; Shannon N Westin; Pamela T Soliman; Robert L Coleman
Journal:  Oncotarget       Date:  2018-08-17

10.  Chemoradiotherapy in combination with radical surgery is associated with better outcome in cervical cancer patients.

Authors:  Dan Zheng; Hua-Ping Mou; Peng Diao; Xiao-Ming Li; Chuan-Li Zhang; Jing Jiang; Jia-Lian Chen; Li-Shuai Wang; Qiu Wang; Guang-Yuan Zhou; Jie Chen; Chuan Lin; Zhi-Ping Yuan
Journal:  Oncotarget       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.